Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hisamitsu Pharmaceutical Co.,Inc.

https://global.hisamitsu/

Latest From Hisamitsu Pharmaceutical Co.,Inc.

Salonpas Samples Its History To Attach US, Canadian Consumers To Topical Analgesics

"Our eyes are more on Advil, Tylenol. We want to be considered first-line treatment for pain, for pain appropriate for what our products are," says Hisamitsu America CEO John Incledon.

Ad Campaigns OTC Drugs

Finance Watch: VC Mega-Rounds Make A Comeback In March

Private Company Edition: After just seven venture capital rounds of $100m or more in January and February, five have been announced already in March, including a $200m series A round for Cargo Therapeutics, Chroma Medicine’s $135m series B financing and $112m for Noema’s series B.

Financing Innovation

BMS Hopes Turning Point Buyout Will Fare Better Than Roche’s Ignyta Acquisition

Bristol Myers Squibb thinks Turning Point’s ROS1/TRK inhibitor shows a best-in-class profile and potential to compete more successfully against Pfizer’s Xalkori than Roche’s Rozlytrek has.

M & A Cancer

Finance Watch: VC Mega-Rounds Are Alive And Well

Private Company Edition: Also, Catalio closed a $381m venture capital fund and OrbiMed’s SEC filings indicate it is in the process of raising $4.75bn across three new funds. Dianthus launched with $100m and Tubulis closed a $63m series B round.

Financing Innovation
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • OTC, Consumer
    • Drug Delivery
      • Transdermal
  • Other Names / Subsidiaries
    • CRCC Media Co.,Ltd. (Fukuoka)
    • Saga City-Vision Co.,Ltd. (Saga)
    • Taiyo Co.,Ltd (Saga)
    • Kyudo Co.,Ltd (Saga)
    • Hisamitsu Agency Co.,Ltd. (Fukuoka)
    • Hisamitsu U.S., Inc.
    • Hisamitsu America, Inc.
    • Noven Pharmaceuticals, Inc.
    • Hisamitsu Farmaceutica do Brasil Ltda.
    • Hisamitsu UK Ltd.
    • Hisamitsu Italia S.r.l.
    • Hisamitsu Vietnam Pharmaceutical Co.,Ltd.
    • Hisamitsu Pharmaceutical(China)Co.,Ltd.
    • Hisamitsu Pharmaceutical Technology Consulting(Beijing) Co.,Ltd.
    • Hisamitsu Pharmaceutical (Hong Kong)Co.,Ltd.
    • PT. Hisamitsu Pharma Indonesia
UsernamePublicRestriction

Register